Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Related structures:
AlphaFold database: A4H3S8
Term | Name | Level | Count |
---|---|---|---|
GO:0008152 | metabolic process | 1 | 1 |
GO:0032259 | methylation | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0008168 | methyltransferase activity | 4 | 1 |
GO:0016740 | transferase activity | 2 | 1 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.454 |
CLV_PCSK_KEX2_1 | 17 | 19 | PF00082 | 0.426 |
DOC_CYCLIN_RxL_1 | 58 | 67 | PF00134 | 0.371 |
DOC_MAPK_gen_1 | 186 | 194 | PF00069 | 0.352 |
DOC_MAPK_MEF2A_6 | 186 | 194 | PF00069 | 0.352 |
DOC_USP7_MATH_1 | 160 | 164 | PF00917 | 0.422 |
DOC_WW_Pin1_4 | 236 | 241 | PF00397 | 0.484 |
LIG_14-3-3_CanoR_1 | 202 | 210 | PF00244 | 0.350 |
LIG_APCC_ABBA_1 | 120 | 125 | PF00400 | 0.262 |
LIG_APCC_ABBA_1 | 139 | 144 | PF00400 | 0.417 |
LIG_FHA_1 | 193 | 199 | PF00498 | 0.350 |
LIG_FHA_1 | 57 | 63 | PF00498 | 0.441 |
LIG_LIR_Apic_2 | 195 | 199 | PF02991 | 0.338 |
LIG_LIR_Gen_1 | 197 | 205 | PF02991 | 0.507 |
LIG_LIR_Gen_1 | 22 | 33 | PF02991 | 0.371 |
LIG_LIR_Gen_1 | 39 | 47 | PF02991 | 0.320 |
LIG_LIR_Gen_1 | 99 | 109 | PF02991 | 0.471 |
LIG_LIR_Nem_3 | 137 | 142 | PF02991 | 0.421 |
LIG_LIR_Nem_3 | 185 | 191 | PF02991 | 0.429 |
LIG_LIR_Nem_3 | 197 | 203 | PF02991 | 0.301 |
LIG_LIR_Nem_3 | 22 | 28 | PF02991 | 0.369 |
LIG_LIR_Nem_3 | 221 | 225 | PF02991 | 0.396 |
LIG_LIR_Nem_3 | 228 | 234 | PF02991 | 0.306 |
LIG_LIR_Nem_3 | 39 | 43 | PF02991 | 0.318 |
LIG_LIR_Nem_3 | 89 | 95 | PF02991 | 0.503 |
LIG_LIR_Nem_3 | 99 | 104 | PF02991 | 0.366 |
LIG_Pex14_1 | 15 | 19 | PF04695 | 0.365 |
LIG_Pex14_1 | 196 | 200 | PF04695 | 0.373 |
LIG_Pex14_2 | 139 | 143 | PF04695 | 0.494 |
LIG_SH2_CRK | 101 | 105 | PF00017 | 0.335 |
LIG_SH2_CRK | 222 | 226 | PF00017 | 0.410 |
LIG_SH2_CRK | 92 | 96 | PF00017 | 0.450 |
LIG_SH2_STAP1 | 101 | 105 | PF00017 | 0.427 |
LIG_SH2_STAP1 | 80 | 84 | PF00017 | 0.505 |
LIG_SH2_STAT3 | 47 | 50 | PF00017 | 0.507 |
LIG_SH2_STAT3 | 9 | 12 | PF00017 | 0.413 |
LIG_SH2_STAT5 | 200 | 203 | PF00017 | 0.414 |
LIG_SH2_STAT5 | 205 | 208 | PF00017 | 0.385 |
LIG_SH3_3 | 235 | 241 | PF00018 | 0.490 |
LIG_TRAF2_1 | 10 | 13 | PF00917 | 0.449 |
LIG_TYR_ITIM | 198 | 203 | PF00017 | 0.374 |
LIG_TYR_ITSM | 97 | 104 | PF00017 | 0.475 |
MOD_CK2_1 | 7 | 13 | PF00069 | 0.417 |
MOD_GlcNHglycan | 100 | 104 | PF01048 | 0.460 |
MOD_GlcNHglycan | 114 | 117 | PF01048 | 0.540 |
MOD_GSK3_1 | 204 | 211 | PF00069 | 0.537 |
MOD_GSK3_1 | 236 | 243 | PF00069 | 0.519 |
MOD_GSK3_1 | 64 | 71 | PF00069 | 0.335 |
MOD_N-GLC_1 | 160 | 165 | PF02516 | 0.313 |
MOD_N-GLC_1 | 218 | 223 | PF02516 | 0.386 |
MOD_N-GLC_1 | 68 | 73 | PF02516 | 0.267 |
MOD_N-GLC_2 | 176 | 178 | PF02516 | 0.240 |
MOD_NEK2_1 | 203 | 208 | PF00069 | 0.407 |
MOD_NEK2_1 | 56 | 61 | PF00069 | 0.502 |
MOD_Plk_1 | 130 | 136 | PF00069 | 0.438 |
MOD_Plk_1 | 160 | 166 | PF00069 | 0.528 |
MOD_Plk_1 | 218 | 224 | PF00069 | 0.482 |
MOD_Plk_1 | 68 | 74 | PF00069 | 0.314 |
MOD_Plk_1 | 99 | 105 | PF00069 | 0.417 |
MOD_Plk_2-3 | 148 | 154 | PF00069 | 0.335 |
MOD_Plk_4 | 27 | 33 | PF00069 | 0.435 |
MOD_ProDKin_1 | 236 | 242 | PF00069 | 0.496 |
MOD_SUMO_rev_2 | 75 | 85 | PF00179 | 0.522 |
TRG_ENDOCYTIC_2 | 101 | 104 | PF00928 | 0.340 |
TRG_ENDOCYTIC_2 | 188 | 191 | PF00928 | 0.332 |
TRG_ENDOCYTIC_2 | 200 | 203 | PF00928 | 0.300 |
TRG_ENDOCYTIC_2 | 222 | 225 | PF00928 | 0.376 |
TRG_ENDOCYTIC_2 | 25 | 28 | PF00928 | 0.381 |
TRG_ENDOCYTIC_2 | 92 | 95 | PF00928 | 0.456 |
TRG_ER_diArg_1 | 17 | 19 | PF00400 | 0.445 |
TRG_Pf-PMV_PEXEL_1 | 170 | 174 | PF00026 | 0.480 |
TRG_Pf-PMV_PEXEL_1 | 223 | 227 | PF00026 | 0.502 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HTY0 | Leptomonas seymouri | 70% | 99% |
A0A0S4IH71 | Bodo saltans | 41% | 92% |
A0A0S4J8X8 | Bodo saltans | 41% | 100% |
A0A1X0NMV1 | Trypanosomatidae | 47% | 100% |
A0A3S5H574 | Leishmania donovani | 87% | 100% |
A0A422NN81 | Trypanosoma rangeli | 44% | 100% |
A4HS03 | Leishmania infantum | 86% | 100% |
C9ZY01 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
E9AJZ1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
P0DPD7 | Homo sapiens | 32% | 96% |
P0DPE0 | Mus musculus | 31% | 96% |
P0DPE1 | Bos taurus | 28% | 96% |
Q95Z88 | Leishmania major | 87% | 100% |
V5BI94 | Trypanosoma cruzi | 45% | 100% |